SCHEMBL31667167

SCHEMBL31667167

N#Cc1ccncc1CC1c2ccccc2C(=O)N1Cc1ccc2[nH]c(=O)oc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 3/20 0.39
▸ IL4I1 Q96RQ9 1/20 0.37
▸ HTR1A P08908 1/20 0.36
▸ DRD2 P14416 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ PDE10A Q9Y233 1/20 0.35
▸ HPGD P15428 2/20 0.34
▸ PDE3B Q13370 1/20 0.34
▸ PDE3A Q14432 1/20 0.34
▸ FNTA P49354 1/20 0.33
▸ FNTB P49356 1/20 0.33
▸ PGGT1B P53609 1/20 0.33
▸ MAPT P10636 3/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ LMNA P02545 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ GRIN1 Q05586 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31667275 0.90 IL4I1 (0.40) MAPK1IL4I1HTR1ADRD2ALDH1A1
SCHEMBL31667083 0.87 MAPK1 (0.41) MAPK1IL4I1ALDH1A1PDE10AHPGD
SCHEMBL32686792 0.87 IL4I1 (0.39) MAPK1IL4I1HTR1ADRD2ALDH1A1
SCHEMBL31667701 0.87 NOS1 (0.40) MAPK1IL4I1HTR1ADRD2ALDH1A1
SCHEMBL32687030 0.84 ALDH1A1 (0.44) MAPK1IL4I1ALDH1A1MEN1KMT2A
SCHEMBL31667108 0.84 HTR1A (0.38) MAPK1IL4I1HTR1ADRD2ALDH1A1
SCHEMBL31667675 0.84 IL4I1 (0.38) MAPK1IL4I1HTR1ADRD2ALDH1A1
SCHEMBL31667052 0.84 HTR1A (0.40) MAPK1IL4I1HTR1ADRD2ALDH1A1
SCHEMBL31667687 0.84 HTR1A (0.40) MAPK1IL4I1HTR1ADRD2ALDH1A1
SCHEMBL32686751 0.84 PDE3B (0.42) MAPK1IL4I1ALDH1A1HPGDPDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078130-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF SIRONAX LTD (KY) 2026-03-19 — — US disclosed
EP-4590674-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd (KY) 2025-07-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078130-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF NAMPT, NNMT, SARM1 MAPK1 1908/4885IL4I1 2872/4885HTR1A 1224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback